Global Catecholamine Market Poised for Explosive Growth US$ 9.3 Billion by 2034, Driven by Rising Demand in Neurological and Adrenal Treatments | Future Market Insights [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
Increase in incidence of cardiovascular diseases, including heart failure, hypotension, and shock, is driving the global catecholamines market demand NEWARK, Del, April 02, 2024 (GLOBE NEWSWIRE) -- The global catecholamine market is expected to witness significant growth in the coming years. Its estimated valuation is US$ 4.6 billion in 2024, which is projected to rise to US$ 9.3 billion by 2034. The market is expected to rise at a 7.2% CAGR through 2034. The market growth is attributed to several factors within the healthcare sector, including the increased demand for catecholamine-based therapies to treat neurological disorders such as Parkinson's disease and ADHD, as well as adrenal gland diseases like pheochromocytoma. Recent technological advancements in analytical methods have significantly enhanced the accuracy of diagnosis and efficacy of treatment for catecholamine-related disorders. Rise in research and development activities focused on novel catecholamine-based therapie
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store? [Yahoo! Finance]Yahoo! Finance
- Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss? [Yahoo! Finance]Yahoo! Finance
- Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in the BofA Securities 2024 Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in the BofA Securities 2024 Health Care ConferencePR Newswire
VTRS
Earnings
- 2/28/24 - Miss
VTRS
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/19/24 - Form 4
- 4/19/24 - Form 3
- VTRS's page on the SEC website